R. Cook

发表

Presence of Alternative Lengthening of Telomeres Mechanism in Patients With Glioblastoma Identifies a Less Aggressive Tumor Type With Longer Survival

A. von Deimling, M. Hegi, R. Reddel, 2010, Journal of neuropathology and experimental neurology.

Nuclear accumulation of e-cadherin correlates with loss of cytoplasmic membrane staining and invasion in pituitary adenomas.

A. Gill, K. McDonald, B. Robinson, 2009, The Journal of clinical endocrinology and metabolism.

Hypofractionated adjuvant surgical cavity radiotherapy following resection of limited brain metastasis

R. Cook, N. Little, M. Back, 2020, Journal of Clinical Neuroscience.

Survival of patients following neurosurgical treatment of colorectal adenocarcinoma metastasis in the Northern Sydney–Central Coast area

K. McDonald, R. Cook, M. Biggs, 2008, Journal of Clinical Neuroscience.

Low O6‐methylguanine‐DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours

S. Clark, A. Gill, M. Burt, 2009, Clinical endocrinology.

Post-contrast enhancement as a clinical indicator of prognosis in patients with anaplastic astrocytoma

H. Wheeler, K. McDonald, E. Matar, 2010, Journal of clinical neuroscience.

MGMT expression and pituitary tumours: relationship to tumour biology

A. Gill, W. Kaplan, B. Robinson, 2013, Pituitary.

Redo craniotomy or bevacizumab for symptomatic steroid-refractory true or pseudoprogression following IMRT for glioblastoma.

H. Wheeler, M. Kastelan, R. Cook, 2021, Neuro-oncology practice.

Survival outcome of elderly patients with Glioblastoma Multiforme in their seventy-fifth year or older treated with adjuvant therapy

M. Khasraw, S. Louw, H. Wheeler, 2017 .

Schwannomatosis, sporadic schwannomatosis, and familial schwannomatosis: a surgical series with long-term follow-up. Clinical article.

H. Wheeler, K. McDonald, R. Cook, 2011, Journal of neurosurgery.

Tumefactive multiple sclerosis versus high grade glioma: A diagnostic dilemma

Monish M. Maharaj, J. Parratt, R. Cook, 2022, Surgical neurology international.

Phase II study of Thalidomide in the treatment of recurrent glioblastoma multiforme

N. Pavlakis, H. Wheeler, R. Cook, 2001, Journal of Neuro-Oncology.

miR-124a is frequently down-regulated in glioblastoma and is involved in migration and invasion.

Helen Wheeler, Sanaz Maleki, Raymond Cook, 2011, European journal of cancer.

IQGAP1 and IGFBP2: Valuable Biomarkers for Determining Prognosis in Glioma Patients

Charlie Teo, Glenn Stone, H. Wheeler, 2007, Journal of neuropathology and experimental neurology.

Wnt pathway inhibitors are strongly down-regulated in pituitary tumors.

A. Gill, K. McDonald, B. Robinson, 2008, Endocrinology.

Increasing incidence of glioblastoma multiforme and meningioma, and decreasing incidence of Schwannoma (2000–2008): Findings of a multicenter Australian study

B. Shadbolt, M. Dexter, V. G. Khurana, 2011, Surgical neurology international.

Variation of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation in serial samples in glioblastoma

H. Wheeler, K. McDonald, B. Robinson, 2008, Journal of Neuro-Oncology.

The presence of necrosis and/or microvascular proliferation does not influence survival of patients with anaplastic oligodendroglial tumours: review of 98 patients

J. Simpson, R. Cook, M. Biggs, 2006, Journal of Neuro-Oncology.

The impact of molecular and clinical factors on patient outcome in oligodendroglioma from 20years’ experience at a single centre

Vahid Afaghi, Kerrie L. McDonald, Michael E. Buckland, 2011, Journal of Clinical Neuroscience.

Large tumour volume reduction of IDH-mutated anaplastic glioma involving the insular region following radiotherapy

H. Wheeler, M. Kastelan, R. Cook, 2022, BMC Neurology.

Survival Outcomes of Elderly Patients With Glioblastoma Multiforme in Their 75th Year or Older Treated With Adjuvant Therapy.

M. Khasraw, S. Louw, H. Wheeler, 2017, International journal of radiation oncology, biology, physics.

Survival improvements with adjuvant therapy in patients with glioblastoma

H. Wheeler, M. Kastelan, G. Schembri, 2018, ANZ journal of surgery.

Loss of prostaglandin D2 synthase: a key molecular event in the transition of a low-grade astrocytoma to an anaplastic astrocytoma

H. Wheeler, K. McDonald, Glenn Stone, 2008, Molecular Cancer Therapeutics.

A multicenter study of primary brain tumor incidence in Australia (2000-2008).

Bruce Shadbolt, Sanjiv Jain, Vini G Khurana, 2011, Neuro-oncology.

Survival of glioblastoma patients related to presenting symptoms, brain site and treatment variables

R. Cook, M. Biggs, N. Little, 2006, Journal of Clinical Neuroscience.

Psychiatric morbidity in patients with Parkinson’s disease following bilateral subthalamic deep brain stimulation: literature review

P. Silberstein, G. Malhi, R. Cook, 2008, Acta Neuropsychiatrica.

Focal radiation therapy for limited brain metastases is associated with high rates of local control and low subsequent whole brain radiation therapy

R. Cook, M. Back, M. Stevens, 2019, ANZ journal of surgery.

Low Rate of Subsequent Whole Brain Radiotherapy Following a Policy of Local Therapy with MRI Surveillance for Central Nervous System Oligometastases

R. Cook, M. Back, C. Teo, 2016 .

FET PET in the evaluation of indeterminate brain lesions on MRI: Differentiating glioma from other non-neoplastic causes – A pilot study

D. Bailey, H. Wheeler, P. Roach, 2018, Journal of Clinical Neuroscience.

Low O6‐methylguanine‐DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours

S. Clark, A. Gill, M. Burt, 2009, Clinical endocrinology.